T 0460/22 (BAYER / GADOLINIUM CHELATE COMPOUNDS / MRI CONTRAST AGENTS) of 02.07.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T046022.20240702
- Date of decision
- 2 July 2024
- Case number
- T 0460/22
- Online on
- 16 September 2024
- Petition for review of
- -
- Application number
- 16726531.3
- IPC class
- C07C 229/16C07D 257/02A61K 49/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
- Applicant name
- Bayer Pharma Aktiengesellschaft
- Opponent name
- De Simone & Partners
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Admissibility of appeal (yes)
Amendment after summons - exceptional circumstances (no)
Amendment after summons - new evidence admitted (no)
Inventive step - main request (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.